Rock Weekly: Deconstructing the Fitbit IPO

May 11, 2015

Digital health IPOs are finally heating up. Off the heels of another filing last week, both Fitbit and Evolent Health sent off S-1s to the SEC—each for $100M. No time to read all 130K+ words? Enjoy the tl;dr version of Fitbit’s filing we wrote just for you.

What’s next for these soon-to-be-public companies? The activity tracking pioneer will be defending against the Apple Watch, while, perhaps, population health management company Evolent can stem the rising tide of ER visits the ACA has not prevented.

Headlines

Deconstructing The Fitbit S-1
Rock Health blog

Washington’s Interest In Precision Drugs Is Innovation, Not Cost
National Journal

The Revolution Will Be Digitized
The Washington Post

White House Moves To Fix Two Key Consumer Complaints About ACA
The New York Times

Why Texas Is Missing Out On The Future Of Medicine
Fortune

Fighting Epidemics With Math
Pacific Standard

Rising Cyber Attacks Costing Health System $6B Annually
Bloomberg

Apple Has Plans For Your DNA
Technology Review

Dr. Karen Desalvo To Leave ONC If Confirmed For New HHS Post
Modern Healthcare

Can A Smartwatch Help Prevent A Heart Attack?
KQED

Warby Parker Wants You To Use Your Phone For Eye Exams
Engadget

Rock Health In The News

Tech Companies See Market Opportunity In Healthcare Innovation
Financial Times

Brigham And Women’s To Help Validate Rock Health Portfolio Companies’ Offerings
MobiHealthNews

Wearables Startup Neumitra Gets New Cash Amid Fitbit, Apple Buzz
Xconomy

Funding

Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.
Get our weekly curated take on everything happening in digital health. Sign up for the Rock Weekly.